SK Biopharmaceuticals CEO Lee Dong-hoon speaks at a press event on Monday announcing the joint venture formed between the Korean company and Eurofarma in San Francisco. [SK BIOPHARMACEUTICALS] SAN ...

SK Biopharmaceuticals, a biotech company focusing on the research, development and commercialization of treatments for disorders of the central nervous system and oncology worldwide, announced a ...

1 Day 326030 0.46% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% ...

As global markets experience a rebound, with major U.S. stock indexes climbing higher due to cooling inflation and robust bank earnings, the spotlight is on small-cap stocks that could benefit from ...

SAN FRANCISCO -- SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical companies, to commercialize a new AI-based epilepsy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aaa Aaaaa A 113.24 +24.19% ...